Early clinical data suggests that this may translate into anti-cancer and tumor growth inhibitive effects—Metformin was administered to HNSCC patients and flow cyometry results taken before and after administration subsequently demonstrated expanded natural killer cell populations, increased anti-tumorigenic cytokine profiles and a change in CD8+ T cell memory phenotypes [96]. The gene discussed is CD8A; the disease is neoplasm.